vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Fabrinet (FN). Click either name above to swap in a different company.
Fabrinet is the larger business by last-quarter revenue ($1.1B vs $749.2M, roughly 1.5× CLOVER HEALTH INVESTMENTS, CORP.). Fabrinet runs the higher net margin — 9.9% vs 3.6%, a 6.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 35.9%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 24.4%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
FabrinetFNEarnings & Financial Report
Below is a list of companies having stocks that are included in the S&P MidCap 400 stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies. Although called the S&P 400, the index sometimes contains more than 400 stocks when it includes two or more share classes of stock from one of its component companies.
CLOV vs FN — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $749.2M | $1.1B |
| Net Profit | $27.3M | $112.6M |
| Gross Margin | — | 12.2% |
| Operating Margin | 3.6% | 10.1% |
| Net Margin | 3.6% | 9.9% |
| Revenue YoY | 62.0% | 35.9% |
| Net Profit YoY | — | 30.0% |
| EPS (diluted) | $0.05 | $3.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $749.2M | — | ||
| Q4 25 | $487.7M | $1.1B | ||
| Q3 25 | $496.6M | $978.1M | ||
| Q2 25 | $477.6M | $909.7M | ||
| Q1 25 | $462.3M | $871.8M | ||
| Q4 24 | $337.0M | $833.6M | ||
| Q3 24 | $331.0M | $804.2M | ||
| Q2 24 | $356.3M | $753.3M |
| Q1 26 | $27.3M | — | ||
| Q4 25 | $-49.3M | $112.6M | ||
| Q3 25 | $-24.4M | $95.9M | ||
| Q2 25 | $-10.6M | $87.2M | ||
| Q1 25 | $-1.3M | $81.3M | ||
| Q4 24 | $-22.1M | $86.6M | ||
| Q3 24 | $-9.2M | $77.4M | ||
| Q2 24 | $7.4M | $81.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | 24.5% | 12.3% | ||
| Q2 24 | 30.3% | 12.3% |
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 10.1% | ||
| Q3 25 | -4.9% | 9.6% | ||
| Q2 25 | -2.2% | 9.8% | ||
| Q1 25 | -0.3% | 9.0% | ||
| Q4 24 | -6.4% | 9.5% | ||
| Q3 24 | -2.7% | 9.6% | ||
| Q2 24 | 2.0% | 9.7% |
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 9.9% | ||
| Q3 25 | -4.9% | 9.8% | ||
| Q2 25 | -2.2% | 9.6% | ||
| Q1 25 | -0.3% | 9.3% | ||
| Q4 24 | -6.6% | 10.4% | ||
| Q3 24 | -2.8% | 9.6% | ||
| Q2 24 | 2.1% | 10.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | $3.11 | ||
| Q3 25 | — | $2.66 | ||
| Q2 25 | — | $2.41 | ||
| Q1 25 | — | $2.25 | ||
| Q4 24 | — | $2.38 | ||
| Q3 24 | — | $2.13 | ||
| Q2 24 | — | $2.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.6M | $960.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $339.4M | $2.2B |
| Total Assets | $697.7M | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $177.6M | — | ||
| Q4 25 | $78.3M | $960.8M | ||
| Q3 25 | — | $968.8M | ||
| Q2 25 | — | $934.2M | ||
| Q1 25 | — | $950.7M | ||
| Q4 24 | $194.5M | $934.6M | ||
| Q3 24 | $288.0M | $908.9M | ||
| Q2 24 | $254.8M | $858.6M |
| Q1 26 | $339.4M | — | ||
| Q4 25 | $308.7M | $2.2B | ||
| Q3 25 | $340.9M | $2.1B | ||
| Q2 25 | $344.2M | $2.0B | ||
| Q1 25 | $336.1M | $1.9B | ||
| Q4 24 | $341.1M | $1.8B | ||
| Q3 24 | $342.2M | $1.8B | ||
| Q2 24 | $324.9M | $1.7B |
| Q1 26 | $697.7M | — | ||
| Q4 25 | $541.0M | $3.3B | ||
| Q3 25 | $559.7M | $3.0B | ||
| Q2 25 | $575.0M | $2.8B | ||
| Q1 25 | $583.7M | $2.6B | ||
| Q4 24 | $580.7M | $2.5B | ||
| Q3 24 | $653.0M | $2.4B | ||
| Q2 24 | $674.2M | $2.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $46.3M |
| Free Cash FlowOCF − Capex | — | $-5.3M |
| FCF MarginFCF / Revenue | — | -0.5% |
| Capex IntensityCapex / Revenue | — | 4.6% |
| Cash ConversionOCF / Net Profit | — | 0.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $102.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-66.9M | $46.3M | ||
| Q3 25 | $12.1M | $102.6M | ||
| Q2 25 | $5.4M | $55.1M | ||
| Q1 25 | $-16.3M | $74.2M | ||
| Q4 24 | $34.8M | $115.9M | ||
| Q3 24 | $50.0M | $83.2M | ||
| Q2 24 | $44.8M | $83.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-69.0M | $-5.3M | ||
| Q3 25 | $11.4M | $57.3M | ||
| Q2 25 | $4.8M | $4.7M | ||
| Q1 25 | $-16.5M | $45.7M | ||
| Q4 24 | $33.3M | $94.0M | ||
| Q3 24 | $49.6M | $62.9M | ||
| Q2 24 | $44.4M | $70.4M |
| Q1 26 | — | — | ||
| Q4 25 | -14.1% | -0.5% | ||
| Q3 25 | 2.3% | 5.9% | ||
| Q2 25 | 1.0% | 0.5% | ||
| Q1 25 | -3.6% | 5.2% | ||
| Q4 24 | 9.9% | 11.3% | ||
| Q3 24 | 15.0% | 7.8% | ||
| Q2 24 | 12.5% | 9.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 4.6% | ||
| Q3 25 | 0.1% | 4.6% | ||
| Q2 25 | 0.1% | 5.5% | ||
| Q1 25 | 0.0% | 3.3% | ||
| Q4 24 | 0.5% | 2.6% | ||
| Q3 24 | 0.1% | 2.5% | ||
| Q2 24 | 0.1% | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.41× | ||
| Q3 25 | — | 1.07× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 1.34× | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | 6.04× | 1.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
